Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
2.010
-0.140 (-6.51%)
Dec 26, 2025, 1:29 PM EST
Nuo Therapeutics Market Cap
Nuo Therapeutics has a market cap or net worth of $96.73 million as of December 26, 2025. Its market cap has increased by 564.84% in one year.
Market Cap
96.73M
Enterprise Value
96.33M
Revenue
2.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.01
Market Cap Chart
Since February 14, 2017, Nuo Therapeutics's market cap has increased from 19.85M to 96.73M, an increase of 387.20%. That is a compound annual growth rate of 19.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 96.73M | 47.58% |
| Dec 31, 2024 | 65.54M | 169.36% |
| Dec 29, 2023 | 24.33M | -61.19% |
| Dec 23, 2022 | 62.70M | 360.46% |
| Dec 31, 2020 | 13.62M | 378.33% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 724.00M |
| Elite Pharmaceuticals | 520.52M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 376.54M |
| CytoDyn | 353.44M |
| Nika Pharmaceuticals | 291.10M |
| Silence Therapeutics | 290.02M |